A US Post-Approval Study of the TAXUS Liberte Paclitaxel-Eluting Coronary Stent System
Research Study on Boston Scientific TAXUS Libert
Not Recruiting
18 years - 100 years
All
Phase
N/A
Brief description of study.
The main purpose of this study is to collect additional information on the Boston Scientific TAXUS Libert
Detailed description of study
The main purpose of this study is to collect additional information on the Boston Scientific TAXUS Libert
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Stents
Age:
18 years - 100 years
Gender: All
Who can participate: Adults aged 18 and older who require percutaneous coronary intervention and meet specific medical criteria are eligible to participate. Key eligibility factors include having a diagnosis that necessitates the use of a coronary stent.
Study details: Participants will undergo a procedure to receive the investigational TAXUS Libert stent. Follow-up visits will be scheduled to monitor the stent's performance and assess patient outcomes.
Updated on
19 Feb 2024.
Study ID: 1010002140
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
